SEC Filing Summary: PerkinElmer, Inc. (Form 8-K)
Business Context and Reporting Period
Company: PerkinElmer, Inc. (formerly EG&G, Inc.)
Filing Date: October 16, 2001 (Event Date)
Reporting Period: The filing primarily addresses the fiscal year ended December 31, 2000, and interim periods through July 1, 2001. It includes unaudited financial statements for the three and six months ended April 1, 2001, and July 1, 2001.
The Company is a global high-technology firm operating in Life Sciences, Optoelectronics, and Instruments segments. The filing details a strategic transformation involving significant acquisitions (NEN Life Sciences, Packard Bioscience) and divestitures.
Key Financial Metrics
| Metric | Fiscal Year 2000 | Q1 2001 (3 mo) | Q2 2001 (3 mo) | YTD 2001 (6 mo) |
|---|---|---|---|---|
| Total Sales | $1,335.5 million | $334.9 million | $331.8 million | $666.7 million |
| Net Income | $90.5 million | $23.5 million | $29.4 million | $52.9 million |
| Income from Continuing Ops | $59.3 million | $13.0 million | $20.0 million | $33.0 million |
| Diluted EPS (Net Income) | $0.89 | $0.23 | $0.28 | $0.51 |
| Cash & Equivalents | $125.6 million | $136.7 million | $133.9 million | $133.9 million |
| Total Debt (Short + Long) | $766.4 million | $811.5 million | $817.7 million | $817.7 million |
| Operating Cash Flow (Continuing) | $98.2 million | ($2.4 million) | N/A | $4.0 million |
Note: Debt figures include short-term commercial paper and long-term convertible debentures. Operating cash flow for Q1 2001 was negative due to working capital changes.
Material Changes vs. Prior Period
- Revenue Growth: Fiscal 2000 revenue increased 27% to $1.34 billion compared to 1999, driven by the acquisition of NEN Life Sciences and organic growth in Life Sciences and Optoelectronics.
- Profitability: Adjusted EPS (excluding nonrecurring items and goodwill amortization) increased 22% in 2000 to $1.05 from $0.86 in 1999. In Q2 2001, operating profit improved due to higher margins and cost controls, despite a 6% revenue decline in the Optoelectronics segment.
- Discontinued Operations: The Company reclassified the Fluid Sciences segment and Security and Detection Systems business as discontinued operations following Board approvals in October and July 2001, respectively. This segregates their results from continuing operations.
- Debt Structure: Long-term debt increased significantly in 2000 due to the issuance of $460 million in zero-coupon senior convertible debentures to finance the NEN acquisition.
Guidance, Outlook, and Risks
Management Commentary:
- Portfolio Shift: Management continues to shift the portfolio toward higher-growth, higher-margin businesses (Life Sciences) while exiting lower-margin or non-core areas.
- Cost Control: Gross margins improved to 47% in Q2 2001 (from 44% in Q2 2000) due to low-cost sourcing and operational efficiencies.
- Restructuring: The Company recorded $15.1 million in restructuring charges in Q4 2000. Cash outlays for restructuring plans totaled $14.7 million in the first six months of 2001, with remaining actions expected in fiscal 2001 and early 2002.
Risks and Contingencies:
- Environmental Liabilities: The Company has accrued $5.4 million for environmental remediation but notes that preliminary investigations make it impossible to estimate the range of potential exposure, which could exceed recorded amounts.
- Acquisition Integration: Risks associated with integrating NEN Life Sciences and the newly acquired Packard Bioscience (completed Nov 13, 2001).
- Forward-Looking Statements: The filing disclaims any obligation to update forward-looking statements regarding future performance, noting that actual results may differ materially due to market conditions and other uncertainties.
Investor Verification Checklist
- Discontinued Operations Impact: Verify the specific financial contribution of the Fluid Sciences and Security/Detection segments to ensure accurate assessment of "Continuing Operations" performance.
- Goodwill Amortization: Review the impact of goodwill amortization from the NEN and AI acquisitions on reported earnings versus "Cash EPS."
- Debt Maturity Profile: Confirm the repayment schedule for the $460 million convertible debentures (due 2020) and the refinancing of revolving credit facilities.
- Environmental Exposure: Assess the potential for material losses exceeding the $5.4 million accrual regarding environmental remediation.
- Stock Split Adjustment: Ensure all per-share data is adjusted for the 2-for-1 stock split effected on June 1, 2001.